FTH Faeth Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $259.2M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $2.9M | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $3.5K | $0 |
| 2023-Q2 | $0 | $5.4M |
| 2023-Q3 | $425 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $574.5K |
| 2026-Q1 | $987.3K | $129.9K |
| 2026-Q2 | $1.4M | $1.6M |
| 2026-Q3 | $117.5K | $0 |
| 2026-Q4 | $0 | $0 |
Bought$6.8M92 buy days
Sold$7.7M18 sell days
Net insider flow-$932.9Knet selling · 5 years
Latest trade2026-07-01STEPHENSON BRIAN C
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | Buy | STEPHENSON BRIAN C | CFO | 5,000 | $23.50 | $117.5K | 2 |
| 2026-06-30 | Buy | STEPHENSON BRIAN C | CFO | 7,803 | $24.25 | $189.2K | 3 |
| 2026-06-29 | Buy | STEPHENSON BRIAN C | CFO | 831 | $23.34 | $19.4K | 1 |
| 2026-06-26 | Buy | STEPHENSON BRIAN C | CFO | 6,250 | $24.95 | $155.9K | 4 |
| 2026-06-24 | Buy | STEPHENSON BRIAN C | CFO | 9,391 | $26.13 | $245.4K | 4 |
| 2026-06-23 | Buy | STEPHENSON BRIAN C | CFO | 9,230 | $24.36 | $224.8K | 3 |
| 2026-06-22 | Buy | STEPHENSON BRIAN C | CFO | 8,183 | $22.13 | $181.1K | 5 |
| 2026-06-22 | Buy | Parikh Anand Kiran | CEO | 2,806 | $19.76 | $55.4K | 1 |
| 2026-06-01 | Sell | Cambrian BioPharma Inc | 10% owner | 25,000 | $20.02 | $500.5K | 2 |
| 2026-06-01 | Sell | Peyer James | 10% owner | 25,000 | $20.02 | $500.5K | 2 |
| 2026-04-07 | Sell | ENGLANDER ISRAEL A | 10% owner | 8,151 | $31.01 | $252.8K | 5 |
| 2026-04-07 | Buy | ENGLANDER ISRAEL A | 10% owner | 1,108 | $33.38 | $37.0K | 1 |
| 2026-04-06 | Sell | ENGLANDER ISRAEL A | 10% owner | 1,259 | $31.05 | $39.1K | 2 |
| 2026-04-06 | Buy | ENGLANDER ISRAEL A | 10% owner | 1,104 | $31.02 | $34.2K | 1 |
| 2026-04-02 | Sell | ENGLANDER ISRAEL A | 10% owner | 7,666 | $32.12 | $246.2K | 5 |
| 2026-04-02 | Buy | ENGLANDER ISRAEL A | 10% owner | 2,003 | $35.01 | $70.1K | 3 |
| 2026-04-01 | Buy | ENGLANDER ISRAEL A | 10% owner | 6,175 | $34.49 | $213.0K | 3 |
| 2026-04-01 | Sell | ENGLANDER ISRAEL A | 10% owner | 1,150 | $31.65 | $36.4K | 2 |
| 2026-03-31 | Buy | ENGLANDER ISRAEL A | 10% owner | 6,005 | $28.16 | $169.1K | 7 |
| 2026-03-31 | Sell | ENGLANDER ISRAEL A | 10% owner | 1,591 | $25.49 | $40.6K | 5 |
| 2026-03-30 | Buy | ENGLANDER ISRAEL A | 10% owner | 9,533 | $25.86 | $246.5K | 4 |
| 2026-03-30 | Sell | ENGLANDER ISRAEL A | 10% owner | 888 | $26.61 | $23.6K | 2 |
| 2026-03-27 | Buy | ENGLANDER ISRAEL A | 10% owner | 15,321 | $26.61 | $407.7K | 3 |
| 2026-03-27 | Sell | ENGLANDER ISRAEL A | 10% owner | 505 | $26.81 | $13.5K | 2 |
| 2026-03-26 | Buy | ENGLANDER ISRAEL A | 10% owner | 5,731 | $28.62 | $164.0K | 4 |
| 2026-03-26 | Sell | ENGLANDER ISRAEL A | 10% owner | 1,857 | $28.12 | $52.2K | 2 |
| 2025-12-09 | Sell | Cambrian BioPharma Inc | 10% owner | 6,612 | $8.25 | $54.6K | 4 |
| 2025-12-09 | Sell | Peyer James | 10% owner | 3,507 | $7.96 | $27.9K | 3 |
| 2025-12-08 | Sell | Peyer James | 10% owner | 3,105 | $8.59 | $26.7K | 1 |
| 2025-12-05 | Sell | Peyer James | 10% owner | 16,295 | $11.50 | $187.4K | 3 |
| 2025-12-05 | Sell | Cambrian BioPharma Inc | 10% owner | 16,295 | $11.50 | $187.4K | 3 |
| 2025-12-04 | Sell | Cambrian BioPharma Inc | 10% owner | 5,000 | $9.06 | $45.3K | 1 |
| 2025-12-04 | Sell | Peyer James | 10% owner | 5,000 | $9.06 | $45.3K | 1 |
| 2023-09-11 | Buy | Celebi John | CEO | 500 | $0.85 | $425 | 1 |
| 2023-06-01 | Sell | Apeiron Investment Group Ltd. | 10% owner | 3,441,661 | $1.58 | $5.4M | 2 |
| 2023-02-23 | Buy | Apeiron Investment Group Ltd. | 10% owner | 2,200 | $1.61 | $3.5K | 2 |
| 2022-03-02 | Buy | Cambrian BioPharma Inc | 10% owner | 1,203 | $3.20 | $3.8K | 1 |
| 2022-03-02 | Buy | Peyer James | Director | 1,203 | $3.20 | $3.8K | 1 |
| 2022-03-01 | Buy | Cambrian BioPharma Inc | 10% owner | 2,458 | $3.60 | $8.8K | 1 |
| 2022-03-01 | Buy | Peyer James | Director | 2,458 | $3.60 | $8.8K | 1 |
| 2022-02-28 | Buy | Peyer James | Director | 42 | $3.60 | $151 | 1 |
| 2022-02-28 | Buy | Cambrian BioPharma Inc | 10% owner | 42 | $3.60 | $151 | 1 |
| 2022-02-25 | Buy | Cambrian BioPharma Inc | 10% owner | 2,500 | $3.65 | $9.1K | 1 |
| 2022-02-25 | Buy | Peyer James | Director | 2,500 | $3.65 | $9.1K | 1 |
| 2022-02-24 | Buy | Cambrian BioPharma Inc | 10% owner | 15,000 | $3.63 | $54.4K | 1 |
| 2022-02-24 | Buy | Peyer James | Director | 15,000 | $3.63 | $54.4K | 1 |
| 2022-02-23 | Buy | Peyer James | Director | 2,500 | $3.80 | $9.5K | 1 |
| 2022-02-23 | Buy | Cambrian BioPharma Inc | 10% owner | 2,500 | $3.80 | $9.5K | 1 |
| 2022-02-18 | Buy | Cambrian BioPharma Inc | 10% owner | 15,000 | $3.97 | $59.6K | 1 |
| 2022-02-18 | Buy | Peyer James | Director | 15,000 | $3.97 | $59.6K | 1 |
| 2022-02-17 | Buy | Peyer James | Director | 4,949 | $4.17 | $20.6K | 1 |
| 2022-02-17 | Buy | Cambrian BioPharma Inc | 10% owner | 4,949 | $4.17 | $20.6K | 1 |
| 2022-02-16 | Buy | Cambrian BioPharma Inc | 10% owner | 2,551 | $4.25 | $10.8K | 1 |
| 2022-02-16 | Buy | Peyer James | Director | 2,551 | $4.25 | $10.8K | 1 |
| 2022-02-14 | Buy | Peyer James | Director | 10,000 | $4.18 | $41.8K | 1 |
| 2022-02-14 | Buy | Cambrian BioPharma Inc | 10% owner | 10,000 | $4.18 | $41.8K | 1 |
| 2022-02-11 | Buy | Peyer James | Director | 12,500 | $4.40 | $55.0K | 1 |
| 2022-02-11 | Buy | Cambrian BioPharma Inc | 10% owner | 12,500 | $4.40 | $55.0K | 1 |
| 2022-02-10 | Buy | Peyer James | Director | 5,000 | $4.58 | $22.9K | 1 |
| 2022-02-10 | Buy | Cambrian BioPharma Inc | 10% owner | 5,000 | $4.58 | $22.9K | 1 |
| 2022-02-08 | Buy | Peyer James | Director | 10,000 | $4.33 | $43.3K | 1 |
| 2022-02-08 | Buy | Cambrian BioPharma Inc | 10% owner | 10,000 | $4.33 | $43.3K | 1 |
| 2022-02-04 | Buy | Peyer James | Director | 2,500 | $4.45 | $11.1K | 1 |
| 2022-02-04 | Buy | Cambrian BioPharma Inc | 10% owner | 2,500 | $4.45 | $11.1K | 1 |
| 2022-02-03 | Buy | Peyer James | Director | 17,500 | $4.65 | $81.4K | 1 |
| 2022-02-03 | Buy | Cambrian BioPharma Inc | 10% owner | 17,500 | $4.65 | $81.4K | 1 |
| 2022-01-28 | Buy | Cambrian BioPharma Inc | 10% owner | 8,900 | $4.22 | $37.6K | 1 |
| 2022-01-28 | Buy | Peyer James | Director | 8,900 | $4.22 | $37.6K | 1 |
| 2022-01-27 | Buy | Cambrian BioPharma Inc | 10% owner | 6,100 | $4.31 | $26.3K | 1 |
| 2022-01-27 | Buy | Peyer James | Director | 6,100 | $4.31 | $26.3K | 1 |
| 2022-01-26 | Buy | Cambrian BioPharma Inc | 10% owner | 29,900 | $4.62 | $138.1K | 1 |
| 2022-01-26 | Buy | Peyer James | Director | 29,900 | $4.62 | $138.1K | 1 |
| 2022-01-25 | Buy | Peyer James | Director | 20,100 | $4.86 | $97.7K | 1 |
| 2022-01-25 | Buy | Cambrian BioPharma Inc | 10% owner | 20,100 | $4.86 | $97.7K | 1 |
| 2022-01-24 | Buy | Peyer James | Director | 22,707 | $4.69 | $106.5K | 1 |
| 2022-01-24 | Buy | Cambrian BioPharma Inc | 10% owner | 22,707 | $4.69 | $106.5K | 1 |
| 2022-01-21 | Buy | Cambrian BioPharma Inc | 10% owner | 24,703 | $4.94 | $122.0K | 1 |
| 2022-01-21 | Buy | Peyer James | Director | 24,703 | $4.94 | $122.0K | 1 |
| 2022-01-20 | Buy | Peyer James | Director | 20,000 | $5.17 | $103.4K | 1 |
| 2022-01-20 | Buy | Cambrian BioPharma Inc | 10% owner | 20,000 | $5.17 | $103.4K | 1 |
| 2022-01-19 | Buy | Cambrian BioPharma Inc | 10% owner | 10,244 | $4.97 | $50.9K | 1 |
| 2022-01-19 | Buy | Peyer James | Director | 10,244 | $4.97 | $50.9K | 1 |
| 2022-01-18 | Buy | Peyer James | Director | 10,000 | $5.08 | $50.8K | 1 |
| 2022-01-18 | Buy | Cambrian BioPharma Inc | 10% owner | 10,000 | $5.08 | $50.8K | 1 |
| 2022-01-14 | Buy | Cambrian BioPharma Inc | 10% owner | 6,219 | $4.99 | $31.0K | 1 |
| 2022-01-14 | Buy | Peyer James | Director | 6,219 | $4.99 | $31.0K | 1 |
| 2022-01-13 | Buy | Peyer James | Director | 19,953 | $5.13 | $102.4K | 1 |
| 2022-01-13 | Buy | Cambrian BioPharma Inc | 10% owner | 19,953 | $5.13 | $102.4K | 1 |
| 2022-01-12 | Buy | Peyer James | Director | 9,202 | $5.22 | $48.0K | 1 |
| 2022-01-12 | Buy | Cambrian BioPharma Inc | 10% owner | 9,202 | $5.22 | $48.0K | 1 |
| 2022-01-11 | Buy | Peyer James | Director | 10,845 | $5.18 | $56.2K | 1 |
| 2022-01-11 | Buy | Cambrian BioPharma Inc | 10% owner | 10,845 | $5.18 | $56.2K | 1 |
| 2022-01-10 | Buy | Peyer James | Director | 10,000 | $5.28 | $52.8K | 1 |
| 2022-01-10 | Buy | Cambrian BioPharma Inc | 10% owner | 10,000 | $5.28 | $52.8K | 1 |
| 2021-12-30 | Buy | 10% owner | 1,127 | $4.85 | $5.5K | 1 | |
| 2021-12-30 | Buy | Peyer James | Director | 1,127 | $4.85 | $5.5K | 1 |
| 2021-12-29 | Buy | Peyer James | Director | 69,000 | $4.98 | $343.6K | 1 |
| 2021-12-29 | Buy | Cambrian BioPharma Inc | 10% owner | 69,000 | $4.98 | $343.6K | 1 |
| 2021-12-28 | Buy | Peyer James | Director | 11,288 | $5.28 | $59.6K | 1 |
| 2021-12-28 | Buy | Cambrian BioPharma Inc | 10% owner | 11,288 | $5.28 | $59.6K | 1 |
| 2021-12-27 | Buy | Cambrian BioPharma Inc | 10% owner | 3,712 | $5.30 | $19.7K | 1 |
| 2021-12-27 | Buy | Peyer James | Director | 3,712 | $5.30 | $19.7K | 1 |
| 2021-12-23 | Buy | Cambrian BioPharma Inc | 10% owner | 11,000 | $5.27 | $58.0K | 1 |
| 2021-12-23 | Buy | Peyer James | Director | 11,000 | $5.27 | $58.0K | 1 |
| 2021-12-17 | Buy | Cambrian BioPharma Inc | 10% owner | 117 | $5.29 | $619 | 1 |
| 2021-12-17 | Buy | Peyer James | Director | 117 | $5.29 | $619 | 1 |
| 2021-12-16 | Buy | Cambrian BioPharma Inc | 10% owner | 10,925 | $5.25 | $57.4K | 1 |
| 2021-12-16 | Buy | Peyer James | Director | 10,925 | $5.25 | $57.4K | 1 |
| 2021-12-10 | Buy | RICKS THOMAS G | Director | 20,000 | $5.86 | $117.2K | 1 |
| 2021-12-09 | Buy | RICKS THOMAS G | Director | 20,000 | $6.62 | $132.4K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Apeiron Investment Group Ltd. | 10% owner | $3.5K | $5.4M | 2023-06-01 |
| Cambrian BioPharma Inc | 10% owner | $2.0M | $787.8K | 2026-06-01 |
| Peyer James | 10% owner | $2.0M | $787.8K | 2026-06-01 |
| ENGLANDER ISRAEL A | 10% owner | $1.3M | $704.4K | 2026-04-07 |
| STEPHENSON BRIAN C | CFO | $1.1M | $0 | 2026-07-01 |
| RICKS THOMAS G | Director | $249.6K | $0 | 2021-12-10 |
| Parikh Anand Kiran | CEO | $55.4K | $0 | 2026-06-22 |
| Celebi John | CEO | $425 | $0 | 2023-09-11 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2021-12-09 → 2022-03-02 | 3 | $4.3M | 50 | -11.8% (-19.9% raw) | -54.1% (-58.9% raw) | -41.9% (-62.3% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.